Literature DB >> 19419520

Reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity in infants of <33 weeks gestation.

Yumiko Tokuhiro1, Tomoko Yoshida, Yoshinobu Nakabayashi, Shohei Nakauchi, Yumi Nakagawa, Minako Kihara, Nobuto Mitsufuji, Zenro Kizaki.   

Abstract

BACKGROUND: The relationship between oxygen and retinopathy of prematurity (ROP) has been studied frequently, and a pulse oximeter has the potential to facilitate the control of oxygen fluctuation in neonates. The objective of the present study was to compare the incidence of threshold ROP (stage 3 requiring laser treatment and stage 4) in infants of <33 weeks gestation after implementing a new clinical O(2) management practice.
METHODS: A retrospective study of data from the Kyoto First Red Cross Hospital neonatal intensive care unit (NICU) from 1 July 2004 to 31 October 2007 (closed 1 December 2006-30 March 2007 for reconstruction). A reduced oxygen protocol was implemented to maintain oxygen saturation (SpO(2)) values using a pulse oximeter between 88% and 92%. The incidence of threshold ROP in the earlier period (1 July 2004-31 December 2005) and the later period (1 January 2006-31 October 2007) were compared.
RESULTS: The incidence of threshold ROP significantly decreased from 32.2% to 16.7%, after changing to the reduced oxygen protocol (P < 0.05).
CONCLUSION: A significant decrease in the rate of threshold ROP in infants of <33 weeks gestation was observed after implementation of the new clinical O(2) management practice.

Entities:  

Mesh:

Year:  2009        PMID: 19419520     DOI: 10.1111/j.1442-200X.2009.02856.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  2 in total

1.  Optimal oxygen saturation in premature infants.

Authors:  Meayoung Chang
Journal:  Korean J Pediatr       Date:  2011-09-30

2.  Aerosol therapy in relation to retinopathy of prematurity in mechanically ventilated preterm infants.

Authors:  Mei-Chin Yang; Hsiu-Feng Hsiao; Hsiu-Li Tseng; Ya-Wen Chiu; Yi-Hao Weng
Journal:  BMC Pulm Med       Date:  2019-08-13       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.